InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: None

Monday, 11/19/2018 2:08:17 PM

Monday, November 19, 2018 2:08:17 PM

Post# of 425931
Why I think scripts will grow quickly.

1. I think doctors who don't put their statin patients on Vascepa risk malpractice suits. Defensive medicine is how medicine is done because doctors hate lawsuits. Standard of care and malpractice will drive script growth.

2. It doesn't really to any of our knowledge have any real negative side effects. Anyone who can bear statins will easily bear Vascepa. So no reason not to prescribe it really.

I guess the biggest question inhibiting rapid growth is whether insurers and/or medicare will resist covering it just based upon the Reduce-It study without a label expansion (with a label expansion they will have little choice). In the short term it will save insurers money most likely on surgeries but in the long term sick older unhealthy patients live longer and that may cost them money.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News